Quantum-Si Incorporated Overview
Latest ROE for Quantum-Si Incorporated: -54.67% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-54.67%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for QSI is -54.67%. That is below the Healthcare sector average of 22.01%. Investors often review this figure alongside Quantum-Si Incorporated's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, QSI currently prints -54.67% for ROE, while the sector average sits near 22.01%. That is roughly 348.4% below the sector mean. Large gaps often invite a closer look at Quantum-Si Incorporated's growth, margins, and balance sheet.
Return on Equity shows how effectively Quantum-Si Incorporated converts resources into returns. At -54.67%, QSI may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting QSI's ROE (-54.67%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Quantum-Si Incorporated's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
